Non-ablative Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Prospective Study on Efficacy, Safety, and Quality of Life and Sexuality Impact

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

January 1, 2025

Conditions
Genitourinary Syndrome of Menopause
Interventions
DEVICE

Leonardo® Diode laser

The intervention involves non-ablative dual-wavelength diode laser therapy for treating Genitourinary Syndrome of Menopause (GSM). This includes three monthly sessions of the Leonardo® Diode laser (Biolitec®), with wavelengths of 980 nm and 1470 nm, delivering 8 pulses per centimeter along the vaginal canal, using local lidocaine gel as an anesthetic. Evaluations are conducted at baseline, 3 months, and 6 months post-treatment.

Trial Locations (1)

09042

RECRUITING

Division of Gynecology and Obstetrics Department of Surgical Sciences, University of Cagliari, Cagliari, Italy, Cagliari

All Listed Sponsors
lead

University of Cagliari

OTHER